Governance Incyte Corporation

INCY

US45337C1027

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-16 pm EST			5-day change	1st Jan Change
106.21 ^USD	+0.92%		-0.62%	+7.53%

Jan. 16	Guggenheim Adjusts Price Target on Incyte to $130 From $125, Maintains Buy Rating	MT
Jan. 15	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE

Executive Committee: Incyte Corporation

Manager

Positions heldSince

William Meury

58 year

Chief Executive Officer	2025-06-25
President	2025-06-25

Benjamin Strain

Investor Relations Contact

2023-08-31

Pablo Cagnoni

62 year

Chief Tech/Sci/R&D Officer	2023-06-04
President	2023-06-04

Thomas Tray

49 year

Comptroller/Controller/Auditor	-
Director of Finance/CFO	2025-09-15

Michael Morrissey

62 year

Chief Tech/Sci/R&D Officer

2015-12-31

Steven Stein

59 year

Chief Tech/Sci/R&D Officer

2015-03-01

Richard A. Hoffman

General Counsel

2025-11-30

Composition of the Board of Directors: Incyte Corporation

Director

CommitteesSince

Julian Baker

59 year

Governance Committee	2025-06-02
Nominating Committee	2025-06-02

Paul Clancy

64 year

Compensation Committee
Audit Committee Chair
Finance Committee Chair
Governance Committee
Nominating Committee
Audit Committee
Governance Committee Chair
Nominating Committee Chair

Jean-Jacques Bienaimé

72 year

Governance Committee	2015-01-19
Nominating Committee	2020-05-12
Compensation Committee Chair
Audit Committee	2023-11-06
Compensation Committee
Governance Committee Chair	2025-10-14
Nominating Committee Chair	2025-10-14

Jacqualyn Fouse

64 year

Audit Committee	2025-06-30
Finance Committee
Governance Committee	2025-06-30
Nominating Committee	2025-06-30

Otis Brawley

66 year

Governance Committee Chair	2021-03-31
Nominating Committee Chair	2021-03-31
Compensation Committee	2021-11-16

Edmund Harrigan

73 year

Audit Committee
Finance Committee

Katherine High

74 year

Governance Committee	2019-06-10
Nominating Committee	2019-06-10

Susanne Antonie Schaffert

59 year

Director/Board Member	2022-09-30
Independent Dir/Board Member	2022-09-30

William Meury

58 year

Director/Board Member

2025-06-25

Latest Appointments: Incyte Corporation

Jan. 07	Palvella Therapeutics, Inc. Appoints Vimal Patel as Senior Vice President of Medical Affairs	CI
Dec. 12	Incyte Corporation Announces Resignation of Hervé Hoppenot from Board of Directors, Effective December 12, 2025	CI
Dec. 01	Incyte appoints Richard Hoffman as executive vice president and general counsel	RE
Dec. 01	Incyte Corporation Announces Executive Changes	CI
25-10-06	Maze Therapeutics Appoints Herve Hoppenot as Board Chairman	MT
25-10-03	Incyte appoints Thomas Tray as principal financial officer - SEC filing	RE
25-09-22	Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer, Effective September 22, 2025	CI

More news

Former Officers and Directors: Incyte Corporation

Insider

Positions held

SinceUntil

Paula Swain

Human Resources Officer

2001-12-31

2025-08-24

Wendy Dixon

Director/Board Member	2010-05-25	2022-06-13
Independent Dir/Board Member	2011-10-26	2022-06-13

Paul Friedman

Director/Board Member	2001-10-31	2021-05-25
Chief Executive Officer	2001-10-31	2014-11-12
Independent Dir/Board Member	2014-11-12	2021-05-25
President	2004-04-30	2014-11-12

Paul Brooke

Director/Board Member	2000-12-31	2020-05-25
Independent Dir/Board Member	2011-10-26	2020-05-25

Victor Sandor

Chief Tech/Sci/R&D Officer

2009-12-31

2019-08-31

Robert Newton

Corporate Officer/Principal

2013-12-31

2018-12-31

Reid Huber

Chief Tech/Sci/R&D Officer	2014-03-31	2018-11-30
Corporate Officer/Principal	2001-12-31	2014-03-31

Richard Levy

Chief Tech/Sci/R&D Officer	2008-12-31	2016-04-29
Corporate Officer/Principal	2003-07-31	2008-12-31

James Daly

Corporate Officer/Principal

2012-10-21

2015-06-25

Richard de Schutter

Chairman	2002-12-31	2015-05-21
Independent Dir/Board Member	2002-12-31	2015-05-21

Barry Michael Ariko

Director/Board Member	2000-12-31	-
Independent Dir/Board Member	2011-10-26	-

David Hastings

Director/Board Member	2003-09-30	2012-06-28
Director of Finance/CFO	2003-09-30	2014-10-30

Roy Whitfield

Director/Board Member	1991-05-31	2001-10-31
Chief Executive Officer	1993-05-31	2001-10-31
Chairman	2001-11-25	2003-05-31
Founder	1991-03-31	2014-05-27
Treasurer	1991-03-31	1991-05-31

Patricia Andrews

Corporate Officer/Principal

2008-10-19

2012-08-28

Brian W. Metcalf

Corporate Officer/Principal

2011-04-30

Patricia A. Schreck

General Counsel	2003-11-30	2010-12-31
Corporate Secretary	2003-11-30	2010-12-31

Kim Solomon

Corporate Officer/Principal

2001-12-31

2010-12-31

Eric Siegel

General Counsel	2010-09-30	-
Corporate Secretary	2011-07-31	-

Matthew Emmens

Director/Board Member

2005-12-31

2009-02-03

John Apeler Keller

Corporate Officer/Principal

2003-08-31

2008-09-11

John F. Niblack

Director/Board Member	2005-12-31	-
Independent Dir/Board Member	2011-10-26	-

Scott W. Hurley

Comptroller/Controller/Auditor	-	2005-04-14
Treasurer	-	2005-04-14

Thomas Theriault

Chief Tech/Sci/R&D Officer

1996-07-31

2004-03-31

Richard D. Goold

Corporate Officer/Principal

2002-10-31

2004-03-31

Laurent Chardonnet

Chief Administrative Officer	-	-
Comptroller/Controller/Auditor	2004-01-31	2015-05-31
Treasurer	2004-01-31	2015-05-31

Elias Bendekgey

Director of Finance/CFO	1997-12-31	2003-12-31
General Counsel	1997-12-31	2003-12-31

James P. Merryweather

Corporate Officer/Principal

1999-02-28

2003-12-31

John M. Vuko

Director of Finance/CFO

1999-11-30

2003-09-30

Robert Stein

Chief Tech/Sci/R&D Officer	2000-12-31	2002-12-31
President	2000-12-31	2002-12-31

Wenqing Yao

Corporate Officer/Principal

2011-10-27

Steve Friedman

Chief Tech/Sci/R&D Officer	2001-12-31	2010-06-01
Corporate Officer/Principal	2010-06-01	-

Samuel T. LaBrie

Corporate Officer/Principal

2000-12-31

Tod M. Klingler

Corporate Officer/Principal

Jeffrey C. Collison

Founder

2011-07-04

Arthur Donny Strosberg

Founder

2010-10-10

Changsheng Zheng

Corporate Officer/Principal

Michelle D. Nowicki

Corporate Officer/Principal

Bhavnish Parikh

Corporate Officer/Principal

2011-10-27

Howard Goldstein

Corporate Officer/Principal

Michael Margolis

Corporate Officer/Principal

Victor Tong

Corporate Officer/Principal

Joe Don Heath

Corporate Officer/Principal

David J. Hodgson

Corporate Officer/Principal

Kenny Pollock

Corporate Officer/Principal

Steve Lincoln

Corporate Officer/Principal

2010-11-15

Daniel Maravei

Corporate Officer/Principal

2011-10-27

Sameer Harish

Corporate Officer/Principal

Thomas Tisch

Director/Board Member

Paul Chirico

Public Communications Contact

Eric Lachenmeier

Corporate Officer/Principal

Jon Saxe

Director/Board Member

Pamela M. Murphy

Investor Relations Contact	2011-10-26	-
Public Communications Contact	-	-

Stan N. Stukov

Corporate Officer/Principal

Gregory Fusco

Corporate Officer/Principal

Robert Nail

Corporate Officer/Principal

JoeBen Bevirt

Chief Tech/Sci/R&D Officer

Timothy G. Henn

Comptroller/Controller/Auditor	-	-
Director of Finance/CFO	-	-

C. James Dobbins

Corporate Officer/Principal

David Stanley Bailey

Corporate Officer/Principal

Thiru P. Reddy

Corporate Officer/Principal

Mike Hoerres

Corporate Officer/Principal

Luke I. Chen

Corporate Officer/Principal	2010-02-16	-
President	-	2010-02-16

Angeline K. Shashlo

General Counsel

Laurie King

Human Resources Officer

Sameer Rohatgi

Corporate Officer/Principal

Cate Sabatini

Corporate Officer/Principal

Dewayne McNair

Corporate Officer/Principal

Tim Germann

Corporate Officer/Principal

Aaron D. Solomon

Corporate Officer/Principal

Susan E. Daniels

Corporate Officer/Principal

Ward Davidson

Corporate Officer/Principal

Fiona Ford

Corporate Officer/Principal

2009-10-17

Michael Donovan

Corporate Officer/Principal

Debora W. Tingley

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	19
Female	2

Of which Executive Committee

Male	7
Female	0

Of which Directors

Male	9
Female	0

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.3%); - royalties (13.7%); - income from research and cooperation agreements (1%).

Employees

2,617

Sector

Pharmaceuticals

Calendar

Feb. 17 - Q4 2025 Earnings Release (Projected)

More about the company